PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, 236-0004, Japan.\', \'Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, 236-0004, Japan. hiro1234@yokohama-cu.ac.jp.\', \'Cardiovascular and Metabolic Disorders Program, Duke-NUS Medical School, Singapore, Singapore.\', \'Department of Medicine, Mount Sinai Beth Israel, New York, NY, USA.\', \'Department of Molecular Biology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.\', \'Department of Otorhinolaryngology, Head and Neck Surgery, School of Medicine, Yokohama City University, Yokohama, Japan.\', \'Internal Medicine, Kanagawa Dental University, Yokosuka, Japan.\', \'Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, 236-0004, Japan. tamukou@med.yokohama-cu.ac.jp.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1038/s41598-021-96294-8
?:doi
?:hasPublicationType
?:journal
  • Scientific reports
is ?:pmid of
?:pmid
?:pmid
  • 34413390
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.533
?:rankingScore_hIndex
  • 122
is ?:relation_isRelatedTo_publication of
?:title
  • Tissue-specific expression of the SARS-CoV-2 receptor, angiotensin-converting enzyme 2, in mouse models of chronic kidney disease.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all